MT2A and breast carcinoma: The regulation of MT1 and MT2 on breast cancer cells is mainly reflected in promoting the cell cycle [37], inhibiting apoptosis [38], enhancing invasiveness [39], regulating oxidative stress [40], and increasing chemotherapy resistance [41].